Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Consolidated Statements Of Operations And Comprehensive Loss        
Revenue
Operating Expenses        
Research and development 2,737,856 2,133,470 7,847,531 5,619,085
General and administrative 1,450,383 1,555,770 4,949,716 4,374,736
Sales and marketing 259,302 185,795 845,253 662,245
Total Operating Expenses 4,447,541 3,875,035 13,642,500 10,656,066
Operating Loss (4,447,541) (3,875,035) (13,642,500) (10,656,066)
Other Expense        
Interest expense 29,108 17,619 78,646 50,259
Net Loss (4,476,649) (3,892,654) (13,721,146) (10,706,325)
Other Comprehensive Income (Loss)        
Foreign currency translation adjustments 46,350 (32,399) 193,454 60,415
Net Comprehensive Loss $ (4,430,299) $ (3,925,053) $ (13,527,692) $ (10,645,910)
Net Loss per Share - Basic and Diluted $ (0.14) $ (0.15) $ (0.46) $ (0.41)
Weighted Average Shares Outstanding - Basic and Diluted 32,826,924 26,512,195 30,071,635 26,343,101